![](/img/cover-not-exists.png)
A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: A Children's Oncology Group study
Mason Bond, Mark L. Bernstein, Alberto Pappo, Kirk R. Schultz, Mark Krailo, Susan M. Blaney, Peter C. AdamsonVolume:
50
Year:
2008
Language:
english
Pages:
5
DOI:
10.1002/pbc.21132
File:
PDF, 104 KB
english, 2008